Grace Therapeutics (L8S.STU) Q1 2026 Earnings

12FebConfirmed
Q1 2026
-0.24
-0.2
-0.16
-0.12

Details

Expected EPS
-0.23591120000000002
Actual EPS
-0.11795560000000001
Surprise EPS
0.12
Surprise Percent
+50%

Description

Grace Therapeutics (L8S.STU) has reported earnings of -0.11795560000000001 per share for Q1 2026.

0 Comments

Share your thoughts